BioCatalystWatch
AVTXWorkspace / AVTX / OverviewCompany library
Avalo Therapeutics, Inc. logo

Avalo Therapeutics, Inc.

Avalo Therapeutics, Inc. (AVTX)

Price
Market cap
Next catalystExpected 2H 2026Abdakibart — Phase 2 LOTUS · Regulatory meetingCompany presentation ↗
Cash

Chart & Events

Candle interval

Core Clinical

AVTX-010

IL-1β

Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

AVTX-010

IL-1β

Upcoming / outlook

Other pipelines

Abdakibart — Phase 2 LOTUS

IL-1β

PreINDP1P2P3FilingApproved

Partner / License out

IL-18

PreINDP1P2P3FilingApproved

History / paused

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Company funding outlook

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

AVTX PR & News

AVTX SEC archive